Half Year 2024 Apiam Animal Health Ltd Earnings Call Transcript
Key Points
- Revenue increased by 11.4% to $104.4 million compared to the first half of the previous year.
- Gross profit rose by 15.5% to $70.9 million, with gross margin improving from 65.5% to 68%.
- Underlying EBITDA grew by 32.7%, indicating strong operational performance.
- The company reinstated its dividend, declaring an interim dividend of $0.01 per share.
- The Best Mates program saw a 19.3% growth since September, bringing in nearly 1,600 new animals.
- Net debt increased by $2.4 million, reflecting the impact of acquisitions.
- Operating expenses rose by 12.6%, driven by acquisition impacts.
- Like-for-like revenue was down 3.8% due to the impact of restructured clinics.
- The company faces a 30-40% drop in revenue from animals in their second and third years post-COVID boom.
- No further acquisitions are expected in FY24, potentially limiting growth opportunities.
(audio ongoing) [Apiam Animal Health] first half results call for 2024. This morning's call will be hosted by Apiam's CEO, Dr. Chris Richards; and Chief Financial Officer, Matthew White.
They'll start with the company presentation. And after this, you'll have the opportunity to ask questions via the Q&A button at the bottom of your screen.
I'll now hand over to Chris and Matt to start the presentation.
Good morning, everybody, and welcome to the Apiam Animal Health's H1 FY24 Results Presentation. As Catherine outlined, today's presentation will be by myself, Chris Richards, Managing Director; and Matt White, who is our Chief Financial Officer. I'd like to begin by acknowledging the traditional owners of the land in which we are meeting today and also to pay my respects to elders past and present.
If we were to look at the Apiam in the first half, it's being now what could really be described as a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
